Michael B. Hoffman - 29 Aug 2025 Form 4 Insider Report for Annovis Bio, Inc. (ANVS)

Role
Director
Signature
/s/ Maria Maccecchini Attorney-in-Fact
Issuer symbol
ANVS
Transactions as of
29 Aug 2025
Net transactions value
+$34,350
Form type
4
Filing time
03 Sep 2025, 16:41:47 UTC
Previous filing
20 Aug 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hoffman Michael B Director C/O ANNOVIS BIO, INC., 101 LINDENWOOD DR, SUITE 225, MALVERN /s/ Maria Maccecchini Attorney-in-Fact 03 Sep 2025 0001290208

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANVS Common Stock Award $11,400 +5,000 +0.34% $2.28 1,469,929 29 Aug 2025 Direct
transaction ANVS Common Stock Award $11,450 +5,000 +0.34% $2.29 1,474,929 29 Aug 2025 Direct
transaction ANVS Common Stock Award $11,500 +5,000 +0.34% $2.30 1,479,929 29 Aug 2025 Direct
holding ANVS Common Stock 223,357 29 Aug 2025 The 2018 Jane and Michael Hoffman Descendants Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares.